Jef Arnout

5.4k total citations
85 papers, 4.1k citations indexed

About

Jef Arnout is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Rheumatology. According to data from OpenAlex, Jef Arnout has authored 85 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 23 papers in Cardiology and Cardiovascular Medicine and 15 papers in Rheumatology. Recurrent topics in Jef Arnout's work include Platelet Disorders and Treatments (33 papers), Systemic Lupus Erythematosus Research (15 papers) and Hemophilia Treatment and Research (14 papers). Jef Arnout is often cited by papers focused on Platelet Disorders and Treatments (33 papers), Systemic Lupus Erythematosus Research (15 papers) and Hemophilia Treatment and Research (14 papers). Jef Arnout collaborates with scholars based in Belgium, United States and Netherlands. Jef Arnout's co-authors include Jos Vermylen, Hans Deckmyn, Marc Hoylaerts, Kathelijne Peerlinck, Paolo Gresele, J. Vermylen, Rudi Pauwels, Erik De Clercq, Jan Desmyter and Jan Balzarini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Jef Arnout

83 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jef Arnout Belgium 33 1.6k 837 676 610 570 85 4.1k
Björn Wiman Sweden 36 2.7k 1.7× 1.5k 1.8× 188 0.3× 1.1k 1.8× 1.4k 2.5× 92 8.0k
M Dechavanne France 31 1.3k 0.8× 495 0.6× 170 0.3× 529 0.9× 508 0.9× 137 3.1k
Harold R. Roberts United States 50 5.3k 3.4× 899 1.1× 168 0.2× 794 1.3× 698 1.2× 164 7.7k
Adrian C. Newland United Kingdom 51 3.9k 2.5× 262 0.3× 289 0.4× 836 1.4× 1.8k 3.1× 281 8.1k
Walter A. Wuillemin Switzerland 37 1.8k 1.1× 1.1k 1.3× 194 0.3× 665 1.1× 338 0.6× 130 4.6k
F. E. Preston United Kingdom 31 1.1k 0.7× 892 1.1× 137 0.2× 459 0.8× 324 0.6× 90 3.4k
G. Müller‐Berghaus Germany 31 1.8k 1.2× 871 1.0× 105 0.2× 886 1.5× 626 1.1× 111 4.7k
Mario Colucci Italy 33 1.8k 1.1× 683 0.8× 127 0.2× 609 1.0× 662 1.2× 147 4.6k
Laurence Camoin‐Jau France 37 1.0k 0.6× 2.9k 3.5× 272 0.4× 1.6k 2.6× 1.6k 2.8× 96 5.9k
J. Dawes United Kingdom 30 891 0.6× 727 0.9× 124 0.2× 690 1.1× 634 1.1× 133 3.4k

Countries citing papers authored by Jef Arnout

Since Specialization
Citations

This map shows the geographic impact of Jef Arnout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jef Arnout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jef Arnout more than expected).

Fields of papers citing papers by Jef Arnout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jef Arnout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jef Arnout. The network helps show where Jef Arnout may publish in the future.

Co-authorship network of co-authors of Jef Arnout

This figure shows the co-authorship network connecting the top 25 collaborators of Jef Arnout. A scholar is included among the top collaborators of Jef Arnout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jef Arnout. Jef Arnout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rector, Annabel, Marijn Thijssen, Leen Delang, et al.. (2023). Monitoring of SARS‐CoV‐2 concentration and circulation of variants of concern in wastewater of Leuven, Belgium. Journal of Medical Virology. 95(2). e28587–e28587. 20 indexed citations
2.
Moerloose, Philippe de, Guido Reber, Jacek Musiał, & Jef Arnout. (2010). Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. 8(7). 1540–1546. 56 indexed citations
3.
Arnout, Jef, Marc Hoylaerts, & H.R. Lijnen. (2006). Haemostasis. Handbook of experimental pharmacology. 1–41. 37 indexed citations
4.
Claes, Nerée, Frank Buntinx, Johan Vijgen, et al.. (2005). Quality assessment of oral anticoagulation in Belgium, as practiced by a group of general practitioners. Acta Cardiologica. 60(3). 247–253. 6 indexed citations
5.
Laga, Steven, et al.. (2005). Heparin Influences Human Platelet Behavior in Cardiac Surgery With or Without Cardiopulmonary Bypass. Artificial Organs. 29(7). 541–546. 7 indexed citations
6.
Buntinx, Frank, et al.. (2005). The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial. European Heart Journal. 26(20). 2159–2165. 39 indexed citations
7.
Arnout, Jef & J. Vermylen. (2003). Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease. Journal of Thrombosis and Haemostasis. 1(5). 931–942. 82 indexed citations
8.
Vuylsteke, Peter, Daniël Knockaert, Daniël Blockmans, Jef Arnout, & Steven Vanderschueren. (2003). Abdominal pain, hypertension, and thrombocytopenia. The Lancet. 362(9397). 1720–1720. 3 indexed citations
9.
Hecken, Anne Van, Inge De Lepeleire, Jef Arnout, et al.. (2002). Effects of enteric‐coated, low‐dose aspirin on parameters of platelet function. Alimentary Pharmacology & Therapeutics. 16(9). 1683–1688. 18 indexed citations
10.
Geet, Chris Van, et al.. (1998). Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome. Kidney International. 54(4). 1324–1330. 28 indexed citations
11.
Pislaru, Sorin V., et al.. (1998). In vivo effects of contrast media on coronary thrombolysis. Journal of the American College of Cardiology. 32(4). 1102–1108. 21 indexed citations
12.
Freson, Kathleen, Kathelijne Peerlinck, Tania Aguirre, et al.. (1998). Fluorescent chemical cleavage of mismatches for efficient screening of the factor VIII gene. Human Mutation. 11(6). 470–479. 20 indexed citations
13.
Liao, Jun, Jef Arnout, Philippe Vanhove, et al.. (1995). Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs.. PubMed. 6(3). 257–63. 10 indexed citations
14.
Barrett, Jeffrey S., Gail Murphy, Kathelijne Peerlinck, et al.. (1994). Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men. Clinical Pharmacology & Therapeutics. 56(4). 377–388. 111 indexed citations
15.
Arnout, Jef, et al.. (1992). A new lupus anticoagulant neutralization test based on platelet‐derived vesicles. British Journal of Haematology. 80(3). 341–346. 22 indexed citations
16.
Arnout, Jef, Maarten L. Simoons, David de Bono, et al.. (1992). Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA). Journal of the American College of Cardiology. 20(3). 513–519. 65 indexed citations
17.
Capel, P., et al.. (1992). Quality Control in Haemostasis. Acta Clinica Belgica. 47(5). 308–318. 4 indexed citations
18.
Tornai, István, Paul Declerck, Lou A. Smets, et al.. (1991). Measurement of von Willebrand Factor Antigen in Plasma and Platelets with an Enzyme-Linked Immunosorbent Assay Based on Two Murine Monoclonal Antibodies. Pathophysiology of Haemostasis and Thrombosis. 21(3). 125–134. 18 indexed citations
19.
Vermylen, Jos & Jef Arnout. (1990). Influence of the lupus anticoagulant on clotting tests. Clinical Rheumatology. 9(S1). 45–50. 1 indexed citations
20.
Gresele, Paolo, Jef Arnout, M C Coene, Hans Deckmyn, & J. Vermylen. (1986). Leukotriene B4 production by stimulated whole blood: Comparative studies with isolated polymorphonuclear cells. Biochemical and Biophysical Research Communications. 137(1). 334–342. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Björn Wiman Breakdown of academic impact, for papers by M Dechavanne Breakdown of academic impact, for papers by Harold R. Roberts Breakdown of academic impact, for papers by Adrian C. Newland Breakdown of academic impact, for papers by Walter A. Wuillemin Breakdown of academic impact, for papers by F. E. Preston Breakdown of academic impact, for papers by G. Müller‐Berghaus Breakdown of academic impact, for papers by Mario Colucci Breakdown of academic impact, for papers by Laurence Camoin‐Jau Breakdown of academic impact, for papers by J. Dawes
Rankless by CCL
2026